Physician profile
Sharon Lewis
NPI 1114082385
$1,752.46
in general payments reported to CMS, 2019-2025
18 companies · $841 in 2025
The $841 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2021: $14.77 · 2022: $216 · 2023: $210 · 2024: $351 · 2025: $841.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,402.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,401.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $673.69 | 2024-2025 | |
| Neurelis, INC. | $220.57 | 2022-2023 | Valtoco |
| Teva Pharmaceuticals USA, INC. | $147.18 | 2024-2025 | Ajovy, Austedo Xr |
| Ucb, INC. | $136.40 | 2023-2025 | Rystiggo, Zilbrysq |
| Novartis Pharmaceuticals Corporation | $119.76 | 2019 | |
| Biohaven Pharmaceutical Holding Company LTD. | $115.71 | 2022 | |
| Argenx US, INC. | $58.22 | 2025 | Vyvgart Hytrulo |
| Pfizer INC. | $41.80 | 2025 | |
| Neurocrine Biosciences, INC. | $40.18 | 2024-2025 | Ingrezza |
| Biogen, INC. | $40.12 | 2024-2025 | Vumerity, Tysabri |
| Aucta Pharmaceuticals, INC. | $36.11 | 2025 | Motpoly Xr |
| Springworks Therapeutics, INC. | $23.25 | 2025 | Gomekli |
| Jazz Pharmaceuticals INC. | $21.35 | 2025 | |
| Csl Behring | $20.00 | 2024 | Hizentra |
| Allergan, INC. | $14.77 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Xeris Pharmaceuticals, INC. | $14.56 | 2025 | Keveyis |
| Eisai INC. | $14.55 | 2025 | |
| Lundbeck LLC | $14.24 | 2025 | Vyepti |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sharon Lewis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.